Determination of Cefixime inclusion complex with 2-hydroxypropyl-β-cyclodextrin and extraction using DLLME and SIHLLME | ||
| Journal of University of Anbar for Pure Science | ||
| Volume 17, Issue 1, June 2023, Pages 97-106 PDF (796.62 K) | ||
| Document Type: Research Paper | ||
| DOI: 10.37652/juaps.2023.178868 | ||
| Authors | ||
| Araf I. Jabbar* 1; Ali I. Khaleel1; Mohammed Z. Thani2 | ||
| 1Department of Chemistry, College of Science, Tikrit University, Sallah-Aldin, Iraq | ||
| 2Department of Chemistry, College of Science, Al-Mustansiriyah University, Baghdad,Iraq | ||
| Abstract | ||
| Micro-extraction techniques with UV-Vis measurement have been developed and validated for the analysis of Cefixime (CFX) in pure and pharmaceutical form. In this work, the DLLME and SIHLLME methods were employed for the extraction, enrichment and evaluation of CFX in pure form and pharmaceuticals using UV-Vis spectroscopy at 274 and 282 nm, respectively. The type of dispersive and extraction solvents and their volumes, pH, the amount of salt, and the centrifuging time were among the experimental variables that were accomplished. Under the perfect conditions, the procedures were linear in the range of 5.0-100.0 and 1.0-15.0 μg/mL, with a correlation coefficient of determination (R2) of 0.9963 and 0.9984 for DLLME and SIHLLME, respectively, LOD was 3.7 and 0.11 µg/mL. Recovery of the target analyte in pharmaceuticals was 96.5%-102.4%. The method can be easily applied to CFX concentrations above this value, but needs further improvements before it can be used in pharmacokinetic studies where more sensitive methods can be found. A simple, inexpensive, accurate, and precise spectrophotometric assay of CFX in pharmaceutical formulations was developed and validated following DLLME and SIHLLME for routine analysis. | ||
| Keywords | ||
| Microextraction; Cefixime; DLLME; SIHLLMEInclusion | ||
|
Supplementary Files
|
||
| References | ||
|
[1] M. Vanaja and J. Sreeramulu, “Simple HPLC method for the determination of cefixime, ofloxacin and linezolid in solid dosage forms”, INTER. J. RES. PHARM. CHEM., 8(4),p. 530-545,2018 .
[2] L. K. Whittles, P. J. White, and X. Didelot, “Quantifying the fitness benefit and cost of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy,” bioRxiv, p. 121418, 2017.
[3] A. D. Mali, “Zero, first, second order derivative and area under curve spectrophotometric methods for determination of cefixime trihydrate in pharmaceutical formulation,” Int. J. Pharm. Pharm. Sci., vol. 7, no. 6, pp. 321–325, 2015.
[4] A. A. Ramadan, H. Mandil, and M. Dahhan, “UV-VIS Spectrophotometric study for determination of cefixime in pure form and in pharmaceuticals through complexation with Cu (II) using acetate-NaOH buffer in water: methanol,” Int. J. Pharm. Phar. Sci, vol. 5, no. 1, pp. 428–433, 2013.
[5] N. R. Ahmad and F. K. Omar, “Spectrophotometric Determination of Cefiximethrough Schiff’s Base System Using Vanillin Reagents Inpharmaceutical Preparations,” Iraqi Natl. J. Chem., vol. 49, pp. 38–46, 2013.
[6] S. J. Pawar, A. P. Kale, M. P. Amrutkar, J. J. Jagade, N. S. Pore, and A. V Bhosale, “HPTLC estimation of cefixime and cloxacillin in tablet dosage form,” Asian J Res Chem, vol. 3, no. 2, pp. 299–301, 2010.
[7] J. Rao, K. Sethy, and S. Yadav, “Validated HPTLC method for simultaneous quantitation of cefixime and ofloxacin in bulk drug and in pharmaceutical formulation,” Int. J. Compr. Pharm., vol. 2, no. 4, pp. 1–5, 2011.
[8] S. Honda, A. Taga, K. Kakehi, S. Koda, and Y. Okamoto, “Determination of cefixime and its metabolises by high-performance capillary electrophoresis,” J. Chromatogr. A, vol. 590, no. 2, pp. 364–368, 1992.
[9] A. Patwari, M. Dabhi, I. Rathod, U. Desai, B. Suhagia, and M. Sharma, “Simultaneous determination of Ofloxacin and Cefixime in combined tablet dosage form by HPLC and absorbance correction method,” Bull. Pharm. Res., vol. 4, no. 3, pp. 112–117, 2014.
[10] K. S. Khandagle, S. V Gandhi, P. B. Deshpande, and N. V Gaikwad, “A simple and sensitive RPHPLC method for simultaneous estimation of cefixime and ofloxacin in combined tablet dosage form,” Int J Pharm Pharm Sci, vol. 3, no. 1, pp. 46–48, 2011.
[11] H. M. Arshad, S. Gauhar, R. Bano, and I. N. Muhammad, “Development of HPLC-UV method for analysis of cefixime in raw materials and in capsule,” Jordan J. Pharm. Sci., vol. 2, no. 1, pp. 53–65, 2009.
[12] A. Khan et al., “Simultaneous determination of cefdinir and cefixime in human plasma by RP-HPLC/UV detection method: Method development, optimization, validation, and its application to a pharmacokinetic study,” J. Chromatogr. B, vol. 879, no. 24, pp. 2423–2429, 2011.
[13] E. H. K. Adam, A. E. M. Saeed, and I. E. Barakat, “Development and validation of a high performance liquid chromatography method for determination of cefixime trihydrate and its degraded products formed under stress condition of UV light,” Int. J. Pharm. Sci. Res., vol. 3, no. 2, p. 469, 2012.
[14] F. Meng, X. Chen, Y. Zeng, and D. Zhong, “Sensitive liquid chromatography–tandem mass spectrometry method for the determination of cefixime in human plasma: Application to a pharmacokinetic study,” J. Chromatogr. B, vol. 819, no. 2, pp. 277–282, 2005.
[15] Z. Talebpour, H. Pourabdollahi, H. Rafati, A. Abdollahpour, Y. Bashour, and H. Y. Aboul-Enein, “Determination of cefixime by a validated stability-indicating HPLC method and identification of its related substances by LC-MS/MS studies,” Sci. Pharm., vol. 81, no. 2, pp. 493–504, 2013.
[16] J. Shah, M. R. Jan, and S. Shah, “Spectrofluorimetric method for determination and validation of cefixime in pharmaceutical preparations through derivatization with 2-cyanoacetamide,” J. Fluoresc., vol. 21, no. 2, pp. 579–585, 2011.
[17] J. L. Manzoori, M. Amjadi, N. Soltani, and A. Jouyban, “Spectrofluorimetric determination of cefixime using terbium-danofloxacin probe,” Iran. J. Basic Med. Sci., vol. 17, no. 4, p. 256, 2014.
[18] A. Abdollahi and A. Bavili-Tabrizi, “Determination of some cephalosporins in pharmaceutical formulations by a simple and sensitive spectrofluorimetric method,” Pharm. Sci., vol. 22, no. 1, pp. 28–34, 2016.
[19] N. K. Kareem, M. Z. Thani, and K. F. Al-Rawi, “New approach for determination of Phenylephrine HCl in Pure and Pharmaceutical Formulation using a various Microextraction Methods,” Res. J. Pharm. Technol., vol. 15, no. 4, pp. 1648–1652, 2022.
[20] N. K. Kareem and K. F. Al-Rawi, “New microextraction methods for the evaluation of bromhexine HCl in pure and pharmacological formulations.,” Egypt. J. Chem., vol. 65, no. 4, pp. 1–2, 2022.
[21] H. Khalili, K. Farhadi, and M. Moradi, “Salt-induced Homogeneous Liquid-liquid Microextraction as a Rapid Clean-up and Preconcentration Technique for Chromatographic Determination of Diazinon and Cypermethrin in Milk Samples,” Anal. Bioanal. Chem. Res., vol. 7, no. 2, pp. 211–222, 2020.
[22] N. Manousi, S. V Tsiona, and C. K. Zacharis, “Salt-Induced Homogeneous Liquid–Liquid Microextraction of Piroxicam and Meloxicam from Human Urine Prior to Their Determination by HPLC-DAD,” Appl. Sci., vol. 12, no. 13, p. 6658, 2022.
[23] F. Soltanmohammadi, M. A. Moghadam, M. Khoubnasabjafari, and A. Jouyban, “Development of salt induced liquid–liquid extraction combined with amine based deep eutectic solvent-dispersive liquid–liquid microextraction; an efficient analytical method for determination of three anti-seizures in urine samples,” Pharm. Sci., vol. 26, no. 3, pp. 323–331, 2020.
[24] D. D. Perrin, Buffers for pH and metal ion control. Springer Science & Business Media, 2012.
[25] A. W. S. Babitan and N. Gupta, “Method Development and Validation for Determination of cefixime in Bulk dosage Form by Spectrophotometry,” Int. J. Pharm. Sci. Rev. Res., vol. 58, no. 1, pp. 13–16, 2019.
[26] S. A. Darweesh, “Spectrophotometric Determination of Cefixime Following Simple Diazotization and Coupling with?-Naphthol,” Iraqi J. Pharm. Sci. (P-ISSN 1683-3597, E-ISSN 2521-3512), pp. 1–6, 2017.
[27] M. N. Khan and M. Mursaleen, “Determination of cefixime in pure form, in pharmaceutical products and biological samples through fluorescence quenching of eosin Y,” Luminescence, vol. 36, no. 2, pp. 515–524, 2021.
[28] R. Gonzalez-Hernandez, L. Nuevas-Paz, L. Soto-Mulet, M. López-López, and J. Hoogmartens, “Reversed phase high performance liquid chromatographic determination of cefixime in bulk drugs,” J. Liq. Chromatogr. Relat. Technol., vol. 24, no. 15, pp. 2315–2324, 2001.
[29] A. A. Chowdhury, M. A. Brishti, G. Uddin, F. K. Tipu, S. Kabir, and M. S. Amran, “Analytical Method Development and Validation of Cefixime Trihydrate in Bulk and Dosage Form by UV-Visible Spectroscopy,” J. Appl. Pharm. Sci. Res., vol. 4, no. 2, pp. 4–9, 2021.
[30] E. BA, S. ÖZDEMİR, M. G. ÇAĞLAYAN, İ. Murat, and F. O. PALABIYIK, “First derivative spectrophotometric determination of cefixime and cefdinir in pharmaceutical preparations,” Turk J Pharm Sci, vol. 10, no. 3, pp. 321–328, 2013.
[31] E. Kadhim, “Spectrophotometer Determination of Cefixime in pure form and pharmaceutical preparation by Using Cloud point Extraction,” Baghdad Sci. J., vol. 17, no. 2 (SI), p. 614, 2020.
[32] M. R. Keskar and R. M. Jugade, “Spectrophotometric determination of cefixime trihydrate in pharmaceutical formulations based on ion-pair reaction with bromophenol blue,” Anal. Chem. Insights, vol. 10, p. ACI-S28463, 2015.
[33] B. Elias and A. Alfeen, “Determination of cefuroxime axetil and cefixime trihydrate in pharmaceutical dosage forms by RP-HPLC Method,” Pharm Anal Chem, vol. 2, p. 114, 2016.
[34] S. A. Dhahir and N. J. Mohammed, “Cloud point extraction of Cefixime drug by direct (UV-Vis) spectrophotometer and indirect (Flame Atomic Absorption) technique,” in Journal of Physics: Conference Series, 2019, vol. 1234, no. 1, p. 12093.
| ||
|
Statistics Article View: 197 PDF Download: 152 |
||
